Fabrice Egros

Fabrice Egros is currently the Chairman at Multicare Pharmaceuticals Philippines, Inc., Chairman at neo CritiCare Pharma Co., Ltd., Director at Biotechnology Innovation Organization, Director at Generic Health Pty Ltd., Director at YL Biologics Ltd., and President-Corporate Development & Growth Markets at Lupin Ltd. He previously served as the Deputy Chief Executive Officer, COO & Director at NovaMedica LLC, Chairman at Kyowa Pharmaceutical Industry Co., Ltd., Independent Director at Syndax Pharmaceuticals, Inc., SVP-Corporate Business Development & Strategy at UCB SA, Chief Operating Officer at Xanodyne Pharmaceuticals, Inc., SVP-Corporate Business Development & Strategy at UCB Pharma, Inc., Vice President at Sanofi-Aventis U.S.
LLC, President at UCB, Inc., and President at UCB Japan Co. Ltd. Dr. Egros has an undergraduate degree from Harvard University, a graduate degree from the University of Orsay, and undergraduate and doctorate degrees from the University of Chatenay-Malabry.